Literature DB >> 19786581

Pichia pastoris as a host for secretion of toxic saporin chimeras.

Alessio Lombardi1, Sara Bursomanno, Teresa Lopardo, Roberta Traini, Marco Colombatti, Rodolfo Ippoliti, David J Flavell, Sopsamorn U Flavell, Aldo Ceriotti, Maria Serena Fabbrini.   

Abstract

Most of the targeting moieties, such as antibody fragments or growth factor domains, used to construct targeted toxins for anticancer therapy derive from secretory proteins. These normally fold in the oxidative environment of the endoplasmic reticulum, and hence their folding in bacterial cells can be quite inefficient. For instance, only low amounts of properly folded antimetastatic chimera constituted by the amino-terminal fragment of human urokinase (ATF) fused to the plant ribosome-inactivating protein saporin could be recovered. ATF-saporin was instead secreted efficiently when expressed in eukaryotic cells protected from autointoxication with neutralizing anti-saporin antibodies. Pichia pastoris is a microbial eukaryotic host where these domains can fold into a transport-competent conformation and reach the extracellular medium. We show here that despite some host toxicity codon-usage optimization greatly increased the expression levels of active saporin but not those of an active-site mutant SAP-KQ in GS115 (his4) strain. The lack of any toxicity associated with expression of the latter confirmed that toxicity is due to saporin catalytic activity. Nevertheless, GS115 (his4) cells in flask culture secreted 3.5 mg/L of a histidine-tagged ATF-saporin chimera showing an IC(50) of 6 x 10(-11) M against U937 cells, thus demonstrating the suitability of this expression platform for secretion of toxic saporin-based chimeras.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786581     DOI: 10.1096/fj.08-118042

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Translation elongation can control translation initiation on eukaryotic mRNAs.

Authors:  Dominique Chu; Eleanna Kazana; Noémie Bellanger; Tarun Singh; Mick F Tuite; Tobias von der Haar
Journal:  EMBO J       Date:  2013-12-19       Impact factor: 11.598

2.  Targeted tumor therapy by epidermal growth factor appended toxin and purified saponin: an evaluation of toxicity and therapeutic potential in syngeneic tumor bearing mice.

Authors:  Mayank Thakur; Katharina Mergel; Alexander Weng; Benedicta von Mallinckrodt; Roger Gilabert-Oriol; Horst Dürkop; Matthias F Melzig; Hendrik Fuchs
Journal:  Mol Oncol       Date:  2012-12-28       Impact factor: 6.603

3.  Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.

Authors:  Hongling Yuan; Quan Du; Matthew B Sturm; Vern L Schramm
Journal:  Biochemistry       Date:  2015-07-14       Impact factor: 3.162

4.  Reductive activation of type 2 ribosome-inactivating proteins is promoted by transmembrane thioredoxin-related protein.

Authors:  Matteo Pasetto; Erika Barison; Monica Castagna; Pietro Della Cristina; Cristina Anselmi; Marco Colombatti
Journal:  J Biol Chem       Date:  2012-01-06       Impact factor: 5.486

5.  A gene optimization strategy that enhances production of fully functional P-glycoprotein in Pichia pastoris.

Authors:  Jiangping Bai; Douglas J Swartz; Irina I Protasevich; Christie G Brouillette; Patina M Harrell; Ellen Hildebrandt; Brigitte Gasser; Diethard Mattanovich; Andrew Ward; Geoffrey Chang; Ina L Urbatsch
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

Review 6.  Ribosome-inactivating proteins: from plant defense to tumor attack.

Authors:  Maddalena de Virgilio; Alessio Lombardi; Rocco Caliandro; Maria Serena Fabbrini
Journal:  Toxins (Basel)       Date:  2010-11-10       Impact factor: 4.546

Review 7.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.

Authors:  Alfredo Errico Provenzano; Riccardo Posteri; Francesco Giansanti; Francesco Angelucci; Sopsamorn U Flavell; David J Flavell; Maria Serena Fabbrini; Danilo Porro; Rodolfo Ippoliti; Aldo Ceriotti; Paola Branduardi; Riccardo Vago
Journal:  Microb Cell Fact       Date:  2016-11-14       Impact factor: 5.328

Review 9.  Saporin-S6: a useful tool in cancer therapy.

Authors:  Letizia Polito; Massimo Bortolotti; Daniele Mercatelli; Maria Giulia Battelli; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2013-10-07       Impact factor: 4.546

10.  Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.

Authors:  Pietro Della Cristina; Monica Castagna; Alessio Lombardi; Erika Barison; Giovanni Tagliabue; Aldo Ceriotti; Ilias Koutris; Luana Di Leandro; Francesco Giansanti; Riccardo Vago; Rodolfo Ippoliti; Sopsamorn U Flavell; David J Flavell; Marco Colombatti; Maria Serena Fabbrini
Journal:  Microb Cell Fact       Date:  2015-02-13       Impact factor: 6.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.